MultiPhy Announce Cooperation with TeraXion to Produce 80km 100G Network Solution

MultiPhy, Ltd, a global leader in DSP-based high bandwidth CMOS communications semiconductors for Data Center and Metro Connectivity, today announced the achievement of a successful integration and interoperability demonstration of the MP1100Q MLSE Receiver/DEMUX and MP1101Q MUX Chipset with TeraXion’s CS-DCL, the smallest optical chromatic dispersion compensator from the leading manufacturer of optical components and modules for high-speed networks.

As next generation Data Center networks get deployed, the need for inexpensive and low power metro links for 100G transmission becomes greater. Traditionally at the 10G rate, these links have reached up to 80km, otherwise known as the ZR standard. “There is a tremendous amount of interest in providing a solution that fits the performance envelope of the existing10G-ZR links in the network today”, said Neal Neslusan, VP of Marketing and Sales at MultiPhy, Inc. “The combination of MultiPhy’s and TeraXion’s world-class offerings provide a superb solution that can be realized in a low-power, pluggable CFP for these cost sensitive applications.”

The market demands that an 80km 100G solution perform seamlessly in the established 10G network and adapt to special compensation tolerances. The combination of the MultiPhy chipset, with its variable dispersion compensation characteristics, along with the TeraXion device’s unique footprint makes the design in a CFP module a reality. “With an heritage of more than a decade of sustained innovation in FBG technology, TeraXion is now pleased to offer a very compact optical dispersion compensator to extend the reach of future next-generation 100G metro links”, said Martin Guy, VP Product Management and CTO at TeraXion.

MultiPhy will be available for meetings at the OFC show in San Francisco, California on March 11 - 13 in Booth #3179 to discuss this application and other applications of the MP1100Q/MP1101Q chipset as well as future developments. Please contact Neal Neslusan at [email protected], +1 978 302 5700 to arrange for a booth visit.

TeraXion also invites you to stop by their OFC Booth #1902 where the CS-DCL will officially be launched.

About MultiPhy

MultiPhy is a fabless semiconductor innovator of cutting edge digital-signal-processing based integrated circuits for high-speed communications. Founded in 2007 and backed by top VCs, the company's 100Gb/s and 400Gb/s CMOS chipsets for advanced modulation schemes are leading in the technology paradigm shift made necessary by the dramatic increase in network traffic. MultiPhy's solutions make optical networks faster, more scalable, flexible and more cost-effective for Metro and Data Center Connections. MultiPhy's winning team of multidisciplinary talented experts in all aspects of optical communications theory and design, have created differentiated patent pending technologies that are redefining cost effective, high-performance solutions at 100Gb/s and beyond next-generation networks. For more information, please visit www.multi-phy.com

About TeraXion

TeraXion designs, manufactures and markets state-of-the-art optical components and modules for high-speed fiber-optic transmission networks, fiber lasers and optical sensing applications. Its line of chromatic dispersion compensation solutions includes Telcordia-qualified low-loss DCMs and small form factor tunable dispersion compensators for 10, 40 and 100Gb/s direct detection terrestrial and submarine networks. Over the years, TeraXion’s abilities to transform complex technologies into manufacturable high-technology products have been applied to Silicon Photonics (SiPh) and Indium Phosphide (InP) for next-generation 100Gb/s and above modulators and receivers. For more information, please visit www.teraxion.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.